Mohammed Milhem
Clinical trials sponsored by Mohammed Milhem, explained in plain language.
-
Selenium combo shows promise in kidney cancer fight
Disease control OngoingThis study tests whether adding a selenium supplement (SLM) to two standard cancer drugs (axitinib and pembrolizumab) is safe and effective for people with advanced clear cell kidney cancer. About 55 participants will receive the combination therapy. The goal is to see if the sup…
Phase: PHASE1, PHASE2 • Sponsor: Mohammed Milhem • Aim: Disease control
Last updated May 26, 2026 12:13 UTC
-
Could a bone drug shrink cartilage tumors before surgery?
Disease control OngoingThis early-phase trial tests whether zoledronic acid, a drug used to strengthen bones, can help people with a rare cartilage cancer called chondrosarcoma. About 17 adults with tumors that can be removed by surgery will receive the drug before their operation. The main goals are t…
Phase: PHASE1 • Sponsor: Mohammed Milhem • Aim: Disease control
Last updated May 22, 2026 14:05 UTC